The market is changing. Companies are looking to fund their activities with commercial debt on a non-recourse basis. Businesses looking for financing to purchase equipment, real estate, or scale their operations, can access bridge capital through us, for minim US$ 25 million. We offer competitive rates and flexible terms. It is possible to borrow up to US$ 500 million with a fixed interest rate on a non-recourse basis.
We’ve prepared the bridge loan term sheet outlining all the conditions and terms of engagement for this facility. We hope you find it useful in making your decision to raise debt capital through Financely Group. Contact us if you require more info.
Contract Clause | Terms |
---|---|
Lending Area | USA, EEA, Middle East, Africa, India, South-East Asia |
Loan Amount | Minimum US$ 25 Million |
Loan Term | 6 Months — 72 Months |
Loan-to-Value | Up to 135% for Undervalued Assets. On Average 80%. |
Interest Rate | 6.20% Per Annum (APY) |
Amortization | Interest Only |
Reserves | Tax & Insurance Reserves Required |
Origination Fee | 2.00% |
Processing Fee | US$ 62,500 |
Expense Deposit | US$ 300,000 (for Third Party, Investment Banking, Legal & Out-of-Pocket Expenses) |
Prepayment Penalties | No Prepayment Penalties After Minimum 6 Months |
Recourse | Non-Recourse Possible |
Borrower | Special Purpose Vehicle Required |
Valuation Documents | Balance Sheets, Income Statements, Cash Flow Statements, Statements of Shareholders’ Equity |
Grace Period | Up to 90 Days |
Closing Time | As Short as 21 Working Days. Up to 12 weeks for Routine Transactions. |
Repayment Frequency | Monthly (After Grace Period) |
Brokers Fee | Brokers Are Paid 0.50% of The Transaction Face Value by Financely Group |
Use Cases | Import/Export, Real Estate, Leveraged Buyouts, Equipment Financing, Debt Consolidation |
We know that you’re looking for a simple and quick application process. We have a 3-step standard operating procedure which enables borrowers to complete their application within 15 minutes by submitting all relevant documents.